Drug Trial Radar · NCT06526338
Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
315
Planned (sponsor's estimate)
Start
Jul 24, 2024
Primary completion
Dec 2029
Study completion Dec 2030
Sponsor
- Lead sponsor
- Robert C. MartinAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of administration of intratumoral IP-001 injection at different dosages (volume and concentration) following local microwave ablation (MWA) or surgical resection and ablation in patients with hepatocellular carcinoma (HCC).
Conditions
- Hepatocellular Carcinoma
Interventions
1.0% IP-001 for injectionDrug
Participants will receive intratumoral injection of 1.0% IP-001 following local microwave ablation or surgical resection and local microwave ablation
Surgical Resection and Local AblationProcedure
Participants will undergo surgical resection of the tumor and local microwave ablation
Local Ablation AloneProcedure
Participants will have local ablation of the tumor by microwave ablation alone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrence Free SurvivalTime frame: From Date of Randomization until date of documented progression, assessed up to 60 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Louisville
Louisville, Kentucky · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.